EPH TECHNOLOGIES, INC.

is a bioscience company focused on commercializing products based upon extremophile, naturally-occurring microbes and the byproducts produced from the reactions these microbes have in the presence of long chain hydrocarbons. EPH is referred as we, our and us A BRIEF HISTORYFrom Saving the Environment to Saving Lives EPHs initial line of products provided a green solution to problems plaguing the oil industry. A team of researchers discovered that when microbes are pumped down an underperforming oil well, they caused a chemical reaction that broke apart paraffin and asphaltine reducing the clogs in the well annulus and equipment and increasing the flow of oil. E3OR also decreased harmful sulfur dioxide in oil and gas production. During the initial testing of E3OR at a few trial sites in Bakersfield, CA, it was observed that the contaminated soil, saturated with waste

During the initial testing of E3OR at a few trial sites in Bakersfield, CA, it was observed that the contaminated soil, saturated with waste water from the E3OR-treated wells, contained growing organics. This raised questions regarding the degree of hydrocarbon structure reduction. The chief technology officer and co-founder (Michael Saunders) conjectured that the stimulated growth was the result of non-essential protein production, remnant enzymatic activity, or an unexpected beneficial microbial interaction. Mr. Saunders expanded his research to include the causes of the observed benefits on organics. In a bio reactor in an EPH lab in New Mexico, it was found that it triggers chemical reaction of microbes that causes production enzymes and separate out and filter significant quantities of enzymes. These enzymes are liquid gold and form the basis of soil amendment, nutritional supplement and skin care products under development. The evolution of EPH and its products now involve

www.frantechasia.com

EPH has approximately 20 years of research invested in understanding and developing the ECP range of treatments. Most of this research and development has been accomplished under substandard conditions in limited laboratory facilities. EPH has been able to accomplish much more than usual under such conditions through innovative alternative approaches to testing and application of the treatments.
a "clinical trial" being run by a doctor at National Autonomous University in Mexico City (UNAM) where his research staff first confirmed that the serum is non-toxic and without any observable side-effects. Over the past six months this doctor has enrolled approximately 40 patients with various pre-existing health issues, including cancer. EPH PRODUCTS The following is a brief summary of current EPH product offerings. Each of these products consists of, or is derived from, extremophile microbes using our proprietary processing and procurement methods. EOR (Oil Recovery): Is a microbial treatment introduced into oil well borings to convert paraffin and asphaltene compounds into profitable ones through a cold, hydrocarbon cracking effect. When EOR penetrates the formation, the extremophile bacteria continue colonize at the oil/water interface. Even after remediating blockages, the EOR microbes continue to break down longer chain hydrocarbons that congregate at the oil/water interface increasing the quality of recoverable oil and increasing the API Gravity, while reducing the wear and tear on the extraction equipment. In survival mode the EOR microbes also reduce the production of harmful sulfide and hydrogen sulfide gas. ESA (Soil Amendment): ESA is soil additive comprised of non-GMO microorganisms, microbial metabolites, and water soluble microbials that are nontoxic, nonhazardous, nonpathogenic and noncorrosive. The use of ESA in limited trials demonstrated improved growth of organic matter. We are currently formulating ESA for applications in commercial agriculture production and retail home garden products. Protenza IS (Immuno Support): Protenza IS consists of proteins and enzymes extracted from extremophile microbes. Protenza IS as a natural, ingestible serum, that can be used immediately as a dietary supplement which, through the promotion and replication of healthy normal cells and immune cells, has proven qualitative health benefits, the market for which we have only begun to identify. Protenza SKIN: Protenza SKIN consists of two distinct lines of skin support products fortified with our proprietary serum: (i) Protenza DX (dermal repair), skin crme and tonic spray used together to treat skin ailments (including eczema and psoriasis) and (ii) Protenza SC (skin care), a line of skin care products, including facial toner, facial serum, facial cream, facial scrub, body cream, body wash and hair mask. ECP products are intended for use and marketed as dietary supplements and nutriceuticals and not as over the counter (OTC) or pharmaceutical grade drugs. Nevertheless, the empirical results suggest that these supplements may, with further research and development, be appropriate for consideration as drugs. However, we believe the cost of regulation and compliance is prohibitive at this time. EOR System A. Hydrocarbon Cracking- A Green Solution Our E line of products has evolved from a
| June 2012 | FranTechnovation

www.frantechasia.com

decade of research focused on the use of extremophile bacteria and their enzymatic byproducts as non-toxic, green solutions for the treatment of oil wells, transportation pipelines and storage tanks. The EOR system is suitable for wells of any depth, is highly effective (typically penetrating production quantities in one to three days), and is less costly than re-entering production with most conventional technologies. Traditional control methods such as hot oil chemical treating and paraffin scraping are expensive, marginally successful, and temporary at best. In addition, these methods have demonstrated, serious long-term effects (especially in the case of hot oiling) on the economic productive life of the well.

EOR is nontoxic, nonhazardous, nonpathogenic and noncorrosive. It will not harm humans, animals or plant life, and does not require permits from the Environmental Protection Agency for transportation, use, or disposal. One of the most significant problems plaguing the production of oil from existing wells is the build up of paraffin and asphaltene. Paraffin crystallization and deposition in well annulus and tubing structures clogs reservoir flow paths. In addition to reducing the amount of oil extracted, paraffin deposits also increase maintenance costs. Asphaltenes occur in crudes when colloidally suspended solid particles precipitate and collect usually at the bottom of wells.

www.frantechasia.com

EPH has reported the following empirical data points from wells treated with our EOR system: Asphaltene Reduction: oil produced from wells treated with EPH microbes and enzymes has a significantly lower C30>asphaltene range and has a greater purity in both chemical and physical appearance; Paraffin Reduction: EPH microbes and enzymes reduce the paraffin content in wells by as much as 24% within 90 days of inoculation; and Hydrogen Sulfide Reduction: EPH microbes and enzymes reduce naturally occurring hydrogen sulfide gas levels an average of 80% (200 ppm to 40 ppm) within 60 days of inoculation. In addition, the initial documented trial program conducted on approximately 100 wells in the Sooner Trend Field in Oklahoma generated data demonstrating improved yields per well of crude oil of 25-100% and natural gas of 10-30%. The Treatment Process EOR is introduced by gravity feed, or pumped into the well-bore annulus by the EPH on-site technicians. Little or no modification of wellhead plumbing is required to accommodate the treating program. Cutting to the Chase- Treatment of Cancer ECP natural supplement promotes cellular health by infiltrating the immune system with specialized proteins and enzymes, resulting in a reduction in the presence and/or replication of infected cells while conversely promoting replication of healthy normal cells and immune cells. While ECP natural supplement are not marketed as a cure for cancer (unless, under very limited circumstances such marketing is allowed under regulations in foreign market), empirical results demonstrate that the ECP may assist in the reduction and/or eradication of tumor cells. The measurable effect of using of ECP natural supplement is that certain cancer tumors and free radicals have been destroyed in voluntary users. The aggressive nature of the disbursement of the cancerous cells tends to suggest that the ECP enzymes and proteins

which facilitate the reaction are very prolific and likely have more involvement in the immune system response than simply breaking down infected cells, inhibitors or blockers, but also aid in the innate immune system signaling process. Packaging, clarification, purification and specification of the ECP natural supplement are essential to the development of large scale manufacturing and distribution infrastructure. The Journey: What has EPH done this far? EPH has approximately 20 years of research invested in understanding and developing the ECP range of treatments. Most of this research and development has been accomplished under substandard conditions in limited laboratory facilities. EPH has been able to accomplish much more than usual under such conditions through innovative alternative approaches to testing and application of the treatments. Lets Take Step Towards Change Its time for moving the ECP project to commercialization phases. The basic infrastructure required to achieve this are similar to that in pharmaceutical companies. The environment in which ECP treatment technology is developed and clarified must conform to pharmaceutical standards of sterility, contamination and cross-contamination control and precision in production processes. Specific production process sampling and testing procedures require advanced technology and consequently substantial capital investment. The ECP natural supplement is comprised of beneficial enzymes, microbes and proteins. Additionally, ECP is comprised of nonessential, unnecessary or perhaps even adversely effective enzymes, microbes and/or proteins. These are categorized as contaminants. The bio-reaction resulting in ECP has to be clarified, meaning that all of the contaminants need to be removed and culturing processes created for the resultant clarified blend of microbes, enzymes and proteins. To know about the opportunities of licensing EPH Technologies and bringing in the change, get in touch with President@FranTechasia.com
| June 2012 | FranTechnovation